DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» LRRK2
LRRK2
LRRK2 at the Crossroad of Aging and Parkinson's Disease
SI Appendix
Pleiotropic Effects for Parkin and LRRK2 in Leprosy Type-1 Reactions and Parkinson’S Disease
LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1
Download
ISS National Lab Q1FY19 Report Quarterly Report for the Period October 1 – December 31, 2018
Genes Implicated in Familial Parkinson's Disease Provide a Dual
Structural Model of the Dimeric Parkinson's Protein LRRK2
LRRK2 GENETICS and EXPRESSION in the PARKINSONIAN BRAIN Thesis Submitted in Fulfilment of the Degree of Doctor of Philosophy
Comprehensive Analysis of the LRRK2 Gene in Sixty Families with Parkinson’S Disease
NASA Armstrong X-Press, March 2019
LRRK2 Biology from Structure to Dysfunction: Research Progresses, but the Themes Remain the Same Daniel C
Leucine-Rich Repeat Kinase 2 (LRRK2) Interacts with Parkin, and Mutant LRRK2 Induces Neuronal Degeneration
Mitochondrial E3 Ubiquitin Ligase Parkin: Relationships with Other
Structure of LRRK2 in Parkinson's Disease and Model for Microtubule
Unbiased Screen for Interactors of Leucine-Rich Repeat Kinase 2 Supports a Common Pathway for Sporadic and Familial Parkinson Disease
Crystal Structure of the WD40 Domain Dimer of LRRK2
Reciprocal Regulation of Arfgap1 by LRRK2
Top View
LRRK2-Overexpression Viral Vectors
Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
Phosphorylation of LRRK2 by Casein Kinase 1&Alpha
Azkona Et Al. 2015 Increased LRRK2 in PINK1 Mutants
Mutation in LRRK2 Is Frequent in Both Early and Late Onset Parkinson's
The in Situ Structure of Parkinson's Disease-Linked LRRK2
Lrrk2 G2385r
LRRK2 and Parkinson Disease
Clinical Insights Into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics
Assaying the Kinase Activity of LRRK2 in Vitro
Identification of Novel Substrates of Lrrk2, a Parkinson's Disease
Sex Effects on Clinical Features in LRRK2 G2385R Carriers and Non-Carriers in Parkinson's Disease
(Leucine-Rich Repeat Kinase 2) Monoclonal Antibodies Paul DAVIES*1, Kelly M
LRRK2 Exonic Variants Associated with Parkinson's Disease
Crystallizing the Parkinson's Disease Protein LRRK2 Under Microgravity
Genome-Wide Association Studies of LRRK2 Modifiers of Parkinson’S Disease
The Roles of Kinases in Familial Parkinson's Disease
Structural Model of the Dimeric Parkinson's Protein LRRK2